Inventor · disambiguated record
Klaus Orlinger
Also filed as: ORLINGER KLAUS
5 granted patents·13 pending applications·26 citations·filing 2014–2024
77Inventor score
Files withHOOKIPA BIOTECH GMBH18
Top patents by PatentIndex Score
18 records- 0189US10669315B2HPV vaccinesHOOKIPA BIOTECH GMBH·Filed 2016·Granted Jun 2, 2020·7 cites·52 claims
- 0287US11266727B2Arenavirus particles as cancer vaccinesHOOKIPA BIOTECH GMBH·Filed 2016·Granted Mar 8, 2022·4 cites·26 claims
- 0385US10111945B2CMV vaccinesHOOKIPA BIOTECH GMBH·Filed 2014·Granted Oct 30, 2018·13 cites·29 claims
- 0479US11407790B2HPV vaccinesHOOKIPA BIOTECH GMBH·Filed 2020·Granted Aug 9, 2022·1 cites·20 claims
- 0578US11554169B2CMV vaccinesHOOKIPA BIOTECH GMBH·Filed 2018·Granted Jan 17, 2023·1 cites·55 claims
- 0672US2025009860A1Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccinesHOOKIPA BIOTECH GMBH·Filed 2024·Application pending·0 cites
- 0772US2023181725A1Cmv vaccinesHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 0869US2023086859A1Hpv vaccinesHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 0965US2022289797A1Tri-segmented pichinde viruses as vaccine vectorsHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1061US2022257734A1Arenavirus particles as cancer vaccinesHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1161US2025057931A1Combination therapy with arenavirus particles and immune checkpoint modulators or cytokinesHOOKIPA BIOTECH GMBH·Filed 2023·Application pending·0 cites
- 1259US2025073324A1Modified arenavirus particles expressing mutant kras, mutated cancer driver gene, or tumor-associated antigen as cancer immunotherapiesHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1359US2024229073A1Arenaviruses as vectorsHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1456US2024174724A1Arenaviruses used in treatments of prostate cancerHOOKIPA BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1554US2020206334A1Replication-deficient arenavirus particles and tri-segmented arenavirus particles as cancer vaccinesHOOKIPA BIOTECH GMBH·Filed 2017·Application pending·0 cites
- 1649US2023346906A1Cancer treatment strategies using arenavirus vectorsHOOKIPA BIOTECH GMBH·Filed 2021·Application pending·0 cites
- 1745US2020113995A1Arenavirus particles to treat solid tumorsHOOKIPA BIOTECH GMBH·Filed 2018·Application pending·0 cites
- 1844US2019135875A1Tri-segmented pichinde viruses as vaccine vectorsHOOKIPA BIOTECH GMBH·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Klaus Orlinger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →